How to Buy Maplight Therapeutics Stock

Maplight Therapeutics Inc

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.

Maplight Therapeutics stock last closed at $30.70, down 3.67% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Maplight Therapeutics stock is currently +150.82% from its 52-week low of $12.24, and -7.75% from its 52-week high of $33.28.

As of May 1, 2026, there are 42.44M shares of MPLT outstanding. The market cap of MPLT is $1.30B. In the past 24 hours, 226,000 MPLT shares were traded.

How to Buy Maplight Therapeutics Stock

Wondering how to invest in Maplight Therapeutics stock? Here's how.

  1. Figure out where to buy Maplight Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Maplight Therapeutics stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Choose your payment method and add your info.
  4. Analyze Maplight Therapeutics stock: The Maplight Therapeutics ticker symbol is MPLT. Is Maplight Therapeutics stock a good investment? Should you buy shares of MPLT? How do MPLT's underlying business fundamentals look? Do top analysts think Maplight Therapeutics is a good buy? Why has MPLT's stock price moved recently? (Hint: Our stock analysis website can help you figure out if MPLT is a good stock to buy).
  5. Place your MPLT trade: Decide if you will purchase MPLT shares at the current market price or use a limit order to buy MPLT shares at a particular price.
  6. Get key alerts regarding your MPLT investment: Create a watchlist to track your new investment in Maplight Therapeutics shares.

Step 1: Figure out where to buy Maplight Therapeutics stock

You will need an online brokerage account in order to access the NASDAQ market and buy MPLT shares.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our experience, eToro is the best stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global markets: From Tech to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
  • Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in MPLT today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to open your new brokerage account.
  1. Submit your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have opened your account on the stock trading app, your next step is to transfer the money for your investment:

Watch the video below to see the process of transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Maplight Therapeutics stock

After you have decided on the best place to buy Maplight Therapeutics stock, it's very important to research their stock before you buy, so you truly understand the risk and upside.

Maplight Therapeutics quick stats

MPLT Price
$30.70
1w %
3.16%
1y %
N/A
5y %
N/A
P/E
-1.65x
P/B
2.84x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$161.15M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$1.30B
Next Earnings
N/A
Next Dividend
N/A

Maplight Therapeutics Due Diligence Score

WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.

You can see all of the due diligence checks on MPLT's stock page.

Is MPLT stock undervalued?

Analysts use many financial metrics, analyses, models, and charts to gauge MPLT's true value.

Using relative valuations ratios:

  • MPLT may be undervalued based on its P/B ratio of 2.84x, relative to Biotechnology industry P/B ratio of 4.89x

You can do additional valuation research on MPLT's stock here.

How do MPLT Financials look?

Positive Financial Indicators:

  • MPLT has cash burn of 138610000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the MPLT balance sheet.
  • MPLT has $305.31M in cash and short term investments. This is enough to cover its annual cash burn of $138.61M.
  • There are more short-term assets than short-term liabilities on the MPLT balance sheet.
  • MPLT has a low debt to equity ratio of 0.05.

Do analysts think it's a good time to buy MPLT stock

Out of 6 sell side analysts who research MPLT, the consensus analyst rating on Maplight Therapeutics is a Strong Buy

Please note that analyst ratings are not recommendations, nor are they investment advice.

Latest MPLT Analyst Recommendations

Sean Laaman, a top 23% analyst from Morgan Stanley initiates coverage on MPLT with a strong buy rating and announces their MPLT price target of $34.00, on Nov 21, 2025.

You can dive deeper into what analysts are projecting on the Maplight Therapeutics stock forecast page.

MPLT Momentum

SMA10
30.08
SMA20
28.33
SMA50
22.38
SMA100
20.26
SMA200
N/A
MACD
2.62
MACD Signal
2.64
MACD Histogram
-0.03
RSI
62.5
Stochastic %K
71.22
Stochastic %D
71.13
StochRSI %K
17.18
StochRSI %D
15.5

Latest Insiders Trades at MPLT

In the past 12 months, executives and large shareholders at MPLT have bought more shares than they have sold.

Jonathan Gillis, CAAO and PAO of MPLT, was the latest MPLT insider to sell. They sold $522,737.55 worth of MPLT stock on Apr 28, 2026.

Get more info about who owns MPLT stock here.

Does MPLT provide a stable income stream?

No, Maplight Therapeutics doesn't provide an income stream by paying out dividends.

MPLT Social Trading Data

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your MPLT trade

There are two main options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly the best for newer investors.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at an exact price limit, use a limit order.

Press the Open button and your broker will execute the order.

If you want more help buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get key alerts regarding your MPLT investment

Now that you own some MPLT stock, you'll want to stay up-to-date on your new investment.

Put MPLT on a watchlist to monitor your MPLT stock.

MPLT Feed

How to Buy Stock in Maplight Therapeutics

To reiterate, here are the 6 steps you need to take to buy Maplight Therapeutics stock right now:

  1. Figure out where to buy Maplight Therapeutics stock
  2. Create your brokerage account
  3. Fund your brokerage account
  4. Analyze Maplight Therapeutics stock
  5. Place your MPLT trade
  6. Get key alerts regarding your MPLT investment

If you need a brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep tabs on your new investment in Maplight Therapeutics, add MPLT to your watchlist below.

NASDAQ: MPLT
$30.70-1.17 (-3.67%)
Updated May 1, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: MPLT
$30.70-1.17 (-3.67%)
Updated May 1, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Maplight Therapeutics share?

As of May 1, 2026, it costs $30.70 to buy one share of Maplight Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.326 shares of MPLT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Maplight Therapeutics stock?

According to 6 Wall Street analysts who monitor Maplight Therapeutics, their consensus recommendation is to buy Maplight Therapeutics stock.

What is the best way to buy Maplight Therapeutics stock?

One way to place an order for Maplight Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.